Pharmaceutical Composition Containing An Anti-Nucleating Agent

Patent No. EP1819323 (titled "Pharmaceutical Composition Containing An Anti-Nucleating Agent") was filed by Merck & Co., Inc. on Dec 2, 2005. The application was issued on Mar 22, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1819323

MERCK & CO., INC.
Application Number
EP05852790A
Filing Date
Dec 2, 2005
Status
Patent Maintained As Amended
Feb 17, 2023
Publication Date
Mar 22, 2023